Literature DB >> 16866778

GABA-site antagonism and pentobarbital actions do not depend on the alpha-subunit type in the recombinant rat GABA receptor.

M Rahman1, D Zhu, C Lindblad, I-M Johansson, E Holmberg, M Isaksson, M Taube, T Bäckström, M-D Wang.   

Abstract

AIM: The roles of alpha-subunits on the gamma-aminobutyric acid (GABA)-site antagonism and pentobarbital actions were examined in rat recombinant GABA(A) receptors in Xenopus oocytes.
METHODS: Experiments were performed with binary and ternary GABA(A) receptors containing alpha1-, alpha4- or alpha5-subunit by the two-electrode voltage-clamp technique.
RESULTS: The potency of GABA was significantly higher in the alpha1beta2, alpha4beta2 and alpha5beta2 receptors compared with the alpha1beta2gamma2L, alpha4beta2gamma2L and alpha5beta2gamma2L receptors. However, the alpha5beta2 receptor possessed significantly lower GABA efficacy compared with the alpha5beta2gamma2L receptor. While the gamma2-subunit was essential to the potency of GABA, its influence on the apparent GABA-site antagonism was less profound. The antagonist affinity constants (K(B)) of bicuculline inhibition and slopes of Schild plots were similar between all types of ternary and binary receptors except alpha5beta2 receptor which was not tested. The pK(B)s and IC(50)s of the GABA-site antagonism were not significantly different between the alpha1beta2gamma2L, alpha4beta2gamma2L and alpha5beta2gamma2L receptors. Bicuculline blocked pentobarbital-activated currents in a reversible and non-competitive manner with the alpha1beta2gamma2L, alpha4beta2gamma2L, and alpha5beta2gamma2L receptors, indicating an allosteric inhibition of the GABA-site. No significant difference of bicuculline potencies in inhibiting GABA- and pentobarbital-activated currents was found between the alpha1beta2gamma2L, alpha4beta2gamma2L and alpha5beta2gamma2L receptors.
CONCLUSION: The GABA-site antagonism does not depend on the subtype of alpha-subunits. Similarly, pentobarbital activates ternary receptors composed of different alpha-subunits in a bicuculline-sensitive manner. The potencies of bicuculline to inhibit pentobarbital-activated currents are identical with receptors containing alpha1, alpha4 or alpha5-subunit. The alpha1beta2 and alpha4beta2 receptors possess higher GABA potencies compared with the alpha1beta2gamma2L and alpha4beta2gamma2L receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16866778     DOI: 10.1111/j.1748-1716.2006.01593.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  6 in total

1.  GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Drug Alcohol Depend       Date:  2011-09-15       Impact factor: 4.492

Review 2.  Neurosteroid biosynthesis down-regulation and changes in GABAA receptor subunit composition: a biomarker axis in stress-induced cognitive and emotional impairment.

Authors:  Andrea Locci; Graziano Pinna
Journal:  Br J Pharmacol       Date:  2017-06-14       Impact factor: 8.739

3.  Input-specific GABAergic signaling to newborn neurons in adult dentate gyrus.

Authors:  Sean J Markwardt; Jacques I Wadiche; Linda S Overstreet-Wadiche
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

4.  Hibernation induces pentobarbital insensitivity in medulla but not cortex.

Authors:  Keith B Hengen; Mary Behan; Hannah V Carey; Mathew V Jones; Stephen M Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-08-12       Impact factor: 3.619

5.  Effects of prenatal stress on neuroactive steroid responses to acute stress in adult male and female rats.

Authors:  Ying Sze; Paula J Brunton
Journal:  J Neuroendocrinol       Date:  2020-12-03       Impact factor: 3.627

6.  Tricyclic antipsychotics and antidepressants can inhibit α5-containing GABAA receptors by two distinct mechanisms.

Authors:  Konstantina Bampali; Filip Koniuszewski; Luca L Silva; Sabah Rehman; Florian D Vogel; Thomas Seidel; Petra Scholze; Florian Zirpel; Arthur Garon; Thierry Langer; Matthäus Willeit; Margot Ernst
Journal:  Br J Pharmacol       Date:  2022-03-07       Impact factor: 9.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.